There are no barriers to working with us, only opportunities

DATE

October 17, 2024

CATEGORY
FOLLOW US

It has a year since the team in Isreal has joined the LTS family. In that time, we have witnessed the first product launched in the US, the development of a pipeline of multiple clinical trials and increased manufacturing capacities.

Insights from Dr. Andrei Yosef, President and General Manager LTS Device Technologies

The breadth of solutions available to our customers today, allied to our global reach, ensures that LTS Device Technologies is delivering commercially ready, compliant and tailored solutions – all underpinned by the LTS purpose of We CARE. We CREATE. We DELIVER.

Our wearable device platform has witnessed real success in the past year with a handful of clinical trials underway and its first product launch in the US. This is down mainly to the flexibility of the platform providing for volumes from 1mL to 50mL as well as highly viscous formulations. It also helps that the platform has onboard UV-LED disinfection of all non-sterile surfaces. This means that the device can be delivered to the patient fully assembled with its vial or cartridge, without requiring timely and expensive additions of clean room space. This is creating a real buzz with our partners as reflected in our growing development pipeline.

Of course, we cannot ignore that some of the macro environmental factors in this part of the world may have caused some uncertainty, however our people remain resolute in our support of our customers, and we remain 100% operational.

We are now working with several pharma partners, particularly on biologics projects, and the expansion of our manufacturing facility is testament to the trust our partners have in us to deliver in any circumstances.